Ukr.Biochem.J. 2018; Volume 90, Issue 6, Nov-Dec, pp. 21-30

doi: https://doi.org/10.15407/ubj90.06.021

Haemostasis modulation by calix[4]arene methylenebisphosphonic acid C-145 and its sulfur-containing analogue

V. O. Chernyshenko1, O. V. Savchuk1, S. O. Cherenok2,
O. M. Silenko2, A. O. Negelia3, L. O. Kasatkina1, L. V. Pirogova1,
V. A. Didkivskyi1, O. I. Yusova1, V. I. Kalchenko2, L. V. Garmanchuk3,
T. V. Grinenko1, E. V. Lugovskoy1, S. V. Komisarenko1

1Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv;
2Institute of Organic Chemistry, National Academy of Sciences of Ukraine, Kyiv;
3ESC Institute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Ukraine;
e-mail: bio.cherv@gmail.com

C-145 (octasodium salt of calix[4]arene-tetra-methylenebisphosphonic acid) was previously considered as specific anti-сoagulant agent that affects fibrin polymerization and does not notably influence other parameters of coagulation system. C-145S (octasodium salt of thiacalix[4]arene-tetra-methylenebisphosphonic acid) possessing wider hydrophobic hole was expected to be more effective antithrombotic agent than C-145. The aim of present work was to compare the action of both organic compounds on fibrin polymerization, fibrinolysis, platelets and endothelial cells. The change of turbidity during fibrin clot formation induced by APTT-reagent and digestion induced by tPA was estimated. Turbidity study was used for the estimation of polymeric fibrin hydrolysis by plasmin in the presence of thiacalix[4]arene C-145S and calix[4]arene C-145. Effects of thiacalix[4]arene C-145S and calix[4]arene C-145 on the activation of Glu-plasminogen by streptokinase were studied using chromogenic substrate S2251. Platelet aggregation study was performed using aggregometry. Stimulated Ca2+ efflux from endoplasmic reticulum and cytoplasm were determined using specific Ca2+-sensitive probes targeted to endoplasmic reticulum (Mag-Fluo-4) and cytoplasm (FURA-2) by spectrofluorimetry. Both C-145 and C-145S decreased the final turbidity of clot and prolonged clot lysis time in blood plasma in comparison to control value. C-145 was shown to be the more effective fibrinolysis inhibitor when studied in model system of polymerized fibrin desAB. C-145S but not C-145 induced concentration changes of Ca2+ in cytoplasm of resting platelets and significantly inhibited (up to 30%) Ca2+ efflux from endoplasmic reticulum of platelets activated by ADP. Both C-145 and C-145S stimulated the proliferation of endothelial cells of PAE cell line. The effect of C-145S was more prominent. In conclusion, calix[4]arene C 145S proved to be the more potent inhibitor of fibrin polymerization in comparison to C-145, which suggested earlier as anticoagulant agent. C-145S proved to have much more outlined inhibitory action on Ca2+-signaling in platelets and stimulatory effect on endothelial cells proliferation. Thus C-145 remained the most prospective molecular platform for the development of antithrombotic agent.

Keywords: , , , , , ,


References:

  1. Gutsche, C.D. Calixarenes. An Introduction, Monographs in Supramolecular Chemistry. Royal Society of Chemistry, Cambridge. 2008, 276 p.
  2. Vicens, J., Harrowfield, J. Calixarenes in the Nanoworld. Springer Verlag, Dordrecht. 2007, 354 p.
  3. Kalchenko O, Cherenok O, Yushchenko O, Kalchenko V. Complexation of calix[4]arenehydroxymethylphosphonic acids with amino acids. Binding constants determination of the complexes by HPLC method. J Incl Phenom. 2013; 76(1-2): 29-36. CrossRef
  4. Kalchenko VI, Kalchenko O, Cherenok S. Complexation of Calix[4]arene bis-Hydroxymethylenediphosphonic Acid with Amino acids. Binding Constants Determination by RP HPLC Method. French-Ukr J Chem. 2015; 3(2): 93-100. CrossRef
  5. Baldini L, Casnati A, Sansone F, Ungaro R. Calixarene-based multivalent ligands. Chem Soc Rev. 2007 Feb;36(2):254-66. PubMed, CrossRef
  6. Komisarenko SV, Kosterin SO, Lugovskoy EV, Kalchenko VI. Calixarene methylene bisphosphonic acids as promising effectors of biochemical processes. Ukr Biokhim Zhurn. 2013; 85(6): 106-128. CrossRef
  7. Bevza OV, Veklich TO, Shkrabak OA, Rodik RV, Kalchenko VI, Kosterin SO. The calix[4]arene C-107 is highly effective supramolecular inhibitor of the Na+,K(+)-ATPase of plasma membranes. Ukr Biokhim Zhurn. 2013 Mar-Apr;85(2):5-19. (In Ukrainian). PubMed, CrossRef
  8. Lugovskoy EV, Gritsenko PG, Koshel TA, Koliesnik IO, Cherenok SO, Kalchenko OI, Kalchenko VI, Komisarenko SV.  Calix[4]arene methylenebisphosphonic acids as inhibitors of fibrin polymerization. FEBS J. 2011 Apr;278(8):1244-51. PubMed, CrossRef
  9. Chernyshenko VO, Korolova DS, Dosenko VЕ, Pashevin DO, Kalchenko VI, Pirogova LV, Chernyshenko TM, Lugovska OE, Kravchenko NА, Makogonenko YM, Lugovskoy EV, Komisarenko SV. Calix[4]arene C-145 Effects on Plasma Haemostasis. Pharm Anal Acta. 2015; 6(8): 401-406. CrossRef
  10. Chernyshenko VO, Korolova DS, Nikolaienko TV, Dosenko VЕ, Pashevin DO, Kalchenko VI, Cherenok SO, Khranovska NN, Garmanchuk LV, Lugovskoy EV, Komisarenko SV. Calix[4]arene C-145 effects on сellular haemostasis. Biotechnologia Acta. 2016; 9(3): 37-43. CrossRef
  11. Chernyshenko V, Korolova D, Lugovska O, Dosenko V, Pashevin D, Kalchenko V, Nikolaenko T, Harmanchuk L, Lugovskoy E Unexpected anti-platelet and promising proangiogenic effects of calix[4]arene C-145 in vivo. FEBS J. 2015: 282(Suppl. 1): 142.
  12. Chernyshenko VO, Pirogova LV, Didkivskyi VA, Cherenok SO, Dosenko VЕ, Pashevin DO, Kalchenko VI, Makogonenko EM, Lugovskoy EV. Effects of Calix[4]arene C-145 on overall haemostatic potential of blood plasma in vitro and in vivo. J Int Res Med Pharm Sci. 2016; 10(3): 146-151.
  13. Rublenko AM, Urvant LP, Makogonenko EM, Platonova TM, Tsap PIu, Chernyshenko TM, Kolesnikova IM, Fishchenko VO, Lugovskoy EV. Effect of protein C activator on overall haemostasis potential in donor and hip arthroplasty patient plasma. Ukr Biokhim Zhurn. 2011 Sep-Oct;83(5):32-9. (In Ukrainian). PubMed
  14. Cattaneo M, Cerletti C, Harrison P, Hayward CP, Kenny D, Nugent D, Nurden P, Rao AK, Schmaier AH, Watson SP, Lussana F, Pugliano MT, Michelson AD. Recommendations for the Standardization of Light Transmission Aggregometry: A Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH. J Thromb Haemost. 2013; 11(6): 1183-1189. PubMed, CrossRef
  15. Kasatkina LA. 4-Аminopyridine sequesters intracellular Ca(2+) which triggers exocytosis in excitable and non-excitable cells. Sci Rep. 2016 Oct 5;6:34749. PubMed, PubMedCentral, CrossRef
  16. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985 Mar 25;260(6):3440-50. PubMed
  17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assayas. J Immunol Methods. 1983; 65(1-2): 55-63.  CrossRef
  18. He S, Antovic A, Blombäck M. A simple and rapid laboratory method for determination of haemostasis potential in plasma. II. Modifications for use in routine laboratories and research work. Thromb Res. 2001 Sep 1;103(5):355-61. PubMed, CrossRef
  19. Ryan EA, Mockros LF, Weisel JW, Lorand L. Structural origins of fibrin clot rheology. Biophys J. 1999 Nov;77(5):2813-26. PubMed, PubMedCentral, CrossRef
  20. Veklich TA, Shkrabak AA, Slinchenko NN, Mazur II, Rodik RV, Boyko VI, Kalchenko VI, Kosterin SA. Calix[4]arene C-90 selectively inhibits Ca2+,Mg2+-ATPase of myometrium cell plasma membrane. Biochemistry (Mosc). 2014 May;79(5):417-24. PubMed, CrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.